Leila Alem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Leila Alem has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Weidong Huang
University of Technology Sydney
4 shared publications - Azadeh Khayyat
Pathology Department of Medical College of Wisconsin, Milwaukee, WI, USA
3 shared publications - Mohammad Ali Esmaeil Pour
Medical College of Georgia, Augusta University, Rheumatology Department, Augusta, GA, USA
3 shared publications - Branko George Celler
Faculty of Engineering, University of New South Wales, Sydney, Australia
2 shared publications - Craig James
CSIRO Earth Science and Resource Engineering
2 shared publications - Hamid Nasri
Department of Natural Sciences, The University of Georgia, Tbilisi, Georgia
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e8836764
Celastrol Enhanced Doxorubicin‐Mediated Apoptosis in Saos‐2 Osteosarcoma Cells
Background: Osteosarcoma is one of the most lethal types of human malignancy in the world. Natural compounds found in certain plant foods are considered chemotherapeutic agents that exert their effects through antiproliferative, proapoptotic, and pro‐oxidant properties associated with cancer. Objective: In this study, we investigated the effects of celastrol on the doxorubicin‐mediated apoptosis in osteosarcoma cells. Saso‐2 cancer cells were treated with ascending concentrations of doxorubicin and celastrol alone or in combination. Methods: Cytotoxicity was measured using the MTT assay. Flow cytometry with Annexin V‐FITC/PI double staining was performed to quantify apoptotic cell populations. Western blot and quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) were used to measure the protein and mRNA expression levels of apoptosis mediators. An ELISA kit measured apoptosis. Result: In Saos‐2 cells, celastrol enhanced the cytotoxic effects of doxorubicin. A combination of doxorubicin and celastrol had a more potent effect on apoptosis induction and modulation of mRNA and protein levels of key apoptotic mediators, including Bax, Bcl‐2, caspase‐3, cytochrome c, and p53. Conclusion: Overall, this study revealed that doxorubicin and celastrol could significantly potentiate doxorubicin‐mediated apoptosis in osteosarcoma cells.
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1) , e8836764
Open AccessCelastrol Enhanced Doxorubicin‐Mediated Apoptosis in Saos‐2 Osteosarcoma Cells
Background: Osteosarcoma is one of the most lethal types of human malignancy in the world. Natural compounds found in certain plant foods are considered chemotherapeutic agents that exert their effects through antiproliferative, proapoptotic, and pro‐oxidant properties associated with cancer. Objective: In this study, we investigated the effects of celastrol on the doxorubicin‐mediated apoptosis in osteosarcoma cells. Saso‐2 cancer cells were treated with ascending concentrations of doxorubicin and celastrol alone or in combination. Methods: Cytotoxicity was measured using the MTT assay. Flow cytometry with Annexin V‐FITC/PI double staining was performed to quantify apoptotic cell populations. Western blot and quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) were used to measure the protein and mRNA expression levels of apoptosis mediators. An ELISA kit measured apoptosis. Result: In Saos‐2 cells, celastrol enhanced the cytotoxic effects of doxorubicin. A combination of doxorubicin and celastrol had a more potent effect on apoptosis induction and modulation of mRNA and protein levels of key apoptotic mediators, including Bax, Bcl‐2, caspase‐3, cytochrome c, and p53. Conclusion: Overall, this study revealed that doxorubicin and celastrol could significantly potentiate doxorubicin‐mediated apoptosis in osteosarcoma cells.
- Open Access
- 13 January 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13 (2) , e11657
The Mayo Clinic consensus report on membranous nephropathy; a promising step toward better treating the disease
Membranous nephropathy is an immune complex disease caused by subepithelial deposits. The pathological manifestations of membranous nephropathy are considered by the creation of immune complexes in the epithelial cells of the glomerular basement membrane. The established pathologic features of primary membranous nephropathy include subepithelial immune deposits, thickening of the glomerular basement membrane, and podocyte foot process effacement. The clinical implications of pathological features of primary membranous nephropathy include male gender, age, persistent heavy proteinuria, decreased glomerular filtration rate on presentation, and tubulointerstitial fibrosis. Membranous nephropathy is diagnosed through a kidney biopsy, confirming subepithelial immune deposits, thickening of the glomerular basement membrane, and podocyte foot process effacement.
- 13 January 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13 (2) , e11657
Open AccessThe Mayo Clinic consensus report on membranous nephropathy; a promising step toward better treating the disease
Membranous nephropathy is an immune complex disease caused by subepithelial deposits. The pathological manifestations of membranous nephropathy are considered by the creation of immune complexes in the epithelial cells of the glomerular basement membrane. The established pathologic features of primary membranous nephropathy include subepithelial immune deposits, thickening of the glomerular basement membrane, and podocyte foot process effacement. The clinical implications of pathological features of primary membranous nephropathy include male gender, age, persistent heavy proteinuria, decreased glomerular filtration rate on presentation, and tubulointerstitial fibrosis. Membranous nephropathy is diagnosed through a kidney biopsy, confirming subepithelial immune deposits, thickening of the glomerular basement membrane, and podocyte foot process effacement.
- Open Access
- 20 November 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13 (1) , e10641
Nephrotoxicity of checkpoint inhibitors; a current challenge
Immune checkpoint inhibitors work by blocking the "checkpoint" mechanism that tumors use to hide from the immune system, therefore also weakening the immune system. Consequently, checkpoint inhibitors can cause autoimmune reactions, resulting in adverse effects. Prompt identification and management of adverse effects are critical for patients under checkpoint inhibitor therapy due to the potential severity and unpredictability of these immune-related adverse events.
- 20 November 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13 (1) , e10641
Open AccessNephrotoxicity of checkpoint inhibitors; a current challenge
Immune checkpoint inhibitors work by blocking the "checkpoint" mechanism that tumors use to hide from the immune system, therefore also weakening the immune system. Consequently, checkpoint inhibitors can cause autoimmune reactions, resulting in adverse effects. Prompt identification and management of adverse effects are critical for patients under checkpoint inhibitor therapy due to the potential severity and unpredictability of these immune-related adverse events.
- Open Access
- 23 September 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13 (1) , e10642
Cancer in IgA nephropathy; a letter to the editor on current findings
Cancer in IgA nephropathy; a letter to the editor on current findings
- 23 September 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 13 (1) , e10642
Open AccessCancer in IgA nephropathy; a letter to the editor on current findings
Cancer in IgA nephropathy; a letter to the editor on current findings
- Open Access
- 10 September 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 12 (4) , e21514
Cancer in systemic lupus erythematosus; a letter to the editor on current concepts
Cancer in systemic lupus erythematosus; a letter to the editor on current concepts
- 10 September 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 12 (4) , e21514
Open AccessCancer in systemic lupus erythematosus; a letter to the editor on current concepts
Cancer in systemic lupus erythematosus; a letter to the editor on current concepts
- Open Access
- 31 August 2023
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 11 (1) , e11241
Propylthiouracil-induced ANCA-positive vasculitis in Graves’ disease
Implication for health policy/practice/research/medical education: Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis is an infrequent autoimmune disease that involves small vessels. Vasculitis triggers include infections, drugs, and chemicals. Propylthiouracil (PTU) is the most reported drug implicated in the induction of ANCA-associated vasculitis. The involvement of hematological systems, skin, gastrointestinal systems, kidneys, musculoskeletal systems, lungs, and neurological systems are seen in PTU-induced vasculitis. The exact pathogenesis of ANCA induction and PTU-induced vasculitis is not fully understood. Diagnosing PTU-induced ANCA-positive vasculitis involves a combination of clinical, laboratory, imaging, and histopathological findings.
- 31 August 2023
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 11 (1) , e11241
Open AccessPropylthiouracil-induced ANCA-positive vasculitis in Graves’ disease
Implication for health policy/practice/research/medical education: Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis is an infrequent autoimmune disease that involves small vessels. Vasculitis triggers include infections, drugs, and chemicals. Propylthiouracil (PTU) is the most reported drug implicated in the induction of ANCA-associated vasculitis. The involvement of hematological systems, skin, gastrointestinal systems, kidneys, musculoskeletal systems, lungs, and neurological systems are seen in PTU-induced vasculitis. The exact pathogenesis of ANCA induction and PTU-induced vasculitis is not fully understood. Diagnosing PTU-induced ANCA-positive vasculitis involves a combination of clinical, laboratory, imaging, and histopathological findings.
- Open Access
- 30 August 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 12 (4) , e21513
Oncohypertension; treatment of high blood pressure in cancer patients
Oncohypertension; treatment of high blood pressure in cancer patients
- 30 August 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 12 (4) , e21513
Open AccessOncohypertension; treatment of high blood pressure in cancer patients
Oncohypertension; treatment of high blood pressure in cancer patients
- Open Access
- 3 August 2023
- Published by Maad Rayan Publishing Company in Journal of Preventive Epidemiology
- Vol. 8 (2) , e35223
Collapsing glomerulopathy following COVID 19 infection; a mini-review to the recent data
Collapsing glomerulopathy has been delineated as the most common morphological feature in COVID-19 individuals presenting with rapidly progressive renal failure and massive proteinuria. This condition, also known as COVID-19-associated nephropathy, has a poor prognosis. In COVID-19-related collapsing glomerulopathy, an immune dysfunction-mediated "second hit" to podocytes of African origin with APOL1 risk alleles was suggested. However, further research is still required to clarify this aspect of glomerulopathy.
- 3 August 2023
- Published by Maad Rayan Publishing Company in Journal of Preventive Epidemiology
- Vol. 8 (2) , e35223
Open AccessCollapsing glomerulopathy following COVID 19 infection; a mini-review to the recent data
Collapsing glomerulopathy has been delineated as the most common morphological feature in COVID-19 individuals presenting with rapidly progressive renal failure and massive proteinuria. This condition, also known as COVID-19-associated nephropathy, has a poor prognosis. In COVID-19-related collapsing glomerulopathy, an immune dysfunction-mediated "second hit" to podocytes of African origin with APOL1 risk alleles was suggested. However, further research is still required to clarify this aspect of glomerulopathy.
- Open Access
- 31 July 2023
- Published by Maad Rayan Publishing Company in Journal of Preventive Epidemiology
- Vol. 8 (2) , e35206
Gender difference in response to COVID vaccination; a letter to the editor on current findings
Implication for health policy/practice/research/medical education: This study found a difference in the immune response to the COVID vaccine between men and women. Women will have a more robust immune response and show more complications.
- 31 July 2023
- Published by Maad Rayan Publishing Company in Journal of Preventive Epidemiology
- Vol. 8 (2) , e35206
Open AccessGender difference in response to COVID vaccination; a letter to the editor on current findings
Implication for health policy/practice/research/medical education: This study found a difference in the immune response to the COVID vaccine between men and women. Women will have a more robust immune response and show more complications.
- 1 January 2015
- Published by Springer Nature
- p. 39-48
Distributed Collaborative Immersive Virtual Reality Framework for the Mining Industry
- 1 January 2015
- Published by Springer Nature
- p. 39-48
Distributed Collaborative Immersive Virtual Reality Framework for the Mining Industry